Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Does Linzess have a role in IBS with constipation?

Edward Pullen, MD
Meds
October 13, 2012
5 Shares
Share
Tweet
Share

Linzess is a new drug that received FDA approval by Forest Laboratories for use in irritable bowel syndrome (IBS) with constipation and in chronic idiopathic constipation.  It got my attention because of its biochemistry.

Learning about the mechanism of action of new drugs like Linzess reminds me how much more is understood about the molecular biological level of physiologic function of the human body than when I was in med school.  Linzess is felt to act as a guanylate cyclase-C agonist. An agonist increases the activity of a process, the opposite of an antagonist. Linzess seems to act locally on the surface of the inside of the intestinal lining cells and by activation of guanylate cyclase-C increases levels of intracellular cGMP (cyclic guanosine monophosphate) which results in increased levels of chloride and bicarbonate in the intestinal lumen and speeds up gastrointestinal transit.

Never having heard of guanylate cyclase-C before, I looked and found out that it was initially discovered before I went to med school in 1974-5, but as far as I know this is one of the first clinically important results of this study in medicine.

The FDA approved use of Linzess in IBS with constipation is 290 µg orally once daily, and in chronic idiopathic constipation the approved dose of Linzess is 145 µg orally daily. In both conditions, Linzess is best taken at least 30 minutes prior to first meal of the day. Linzess joins previously FDA approved and Amitiza (lubiprostone) as prescription medications specifically for IBS with constipation and gives us one more option for treatment of this difficult problem.

IBS with constipation is among the more common and refractory conditions seen in gastroenterology and in primary care. Chronic laxative use is common in these patients and can lead to laxative dependence, poor colonic function and even toxic megacolon in severe cases. Osmotic laxatives like milk of magnesia and not observable sugars like lactulose are commonly used. Miralax (polyethylene glycol) has become increasingly popular in recent years but all of these products have limited effectiveness and associated problems.

The efficacy of Linzess in IBS with constipation and in chronic idiopathic constipation is expected to be modest. In the placebo trial, improvement was only 33% for improvement both abdominal pain and constipation versus 21% with placebo or a 12.6% benefit. In constipation, 48% improved with Linzess versus 29% on placebo, a 19% difference.

Diarrhea is the most common side effect of Linzess, occurring in up to 20% or patients. Often the diarrhea begins within the first 2 weeks of treatment.  The diarrhea from Linzess can be severe and the manufacturer recommends that if a person develops diarrhea they should immediately stop the medication and contact their doctor.  Other GI symptoms include abdominal pain, gas and a feeling of fullness or swelling in the abdomen.  Linzess comes with a strict warning that it is not for use in children. In juvenile rats deaths were noted, so Linzess is contraindicated for use in persons under age 18.

It is expected that Linzess will be another expensive medication. Although Forest has not yet set a price, they have intimated that the drug will be priced to be comparable to Amitiza, or in the $260 per month range.  It remains to be seen if it will be more popular than Amitiza, or whether it will be just a niche drug for refractory cases of IBS with constipation and chronic idiopathic constipation.

Edward Pullen is a family physician who blogs at DrPullen.com.

Prev

Do drugs aid and abet genius or does genius lead to drugs?

October 13, 2012 Kevin 3
…
Next

Take your flu vaccine as soon as it is available

October 13, 2012 Kevin 7
…

Tagged as: Gastroenterology, Medications

Post navigation

< Previous Post
Do drugs aid and abet genius or does genius lead to drugs?
Next Post >
Take your flu vaccine as soon as it is available

More by Edward Pullen, MD

  • a desk with keyboard and ipad with the kevinmd logo

    Mal de debarquement: Vertigo and dizziness after a cruise

    Edward Pullen, MD
  • a desk with keyboard and ipad with the kevinmd logo

    Proton pump inhibitors and B12 deficiency: What to do now

    Edward Pullen, MD
  • a desk with keyboard and ipad with the kevinmd logo

    5 preventive services to do, and 5 to avoid

    Edward Pullen, MD

More in Meds

  • Levamisole is good for your dog, but bad for your cocaine

    Robert Killeen, MD
  • 13.1 million missing Americans since 1980. Where’s the outrage?

    Steve Burgess, MD
  • Ketamine for mental health conditions: What every primary care physician needs to know

    Carlene MacMillan, MD & L. Alison McInnes, MD
  • Learn to be a Narcan hero: a comic tutorial

    Emily Watters, MD
  • The preference for insurance coverage of opioids over non-pharmaceutical options explained

    Amy Baxter, MD
  • A comic reveals the terrifying truth about fentanyl

    Emily Watters, MD
  • Most Popular

  • Past Week

    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • Unraveling the complex enigma of obesity [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician autonomy and patient interactions in corporate health care

      Michele Luckenbaugh | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
  • Recent Posts

    • Unraveling the complex enigma of obesity [PODCAST]

      The Podcast by KevinMD | Podcast
    • Second chances and simple beauty in thrift stores

      Debbie Moore-Black, RN | Conditions
    • How to facilitate caregiver learning and support to improve clinical care outcomes

      Kerri Milyko, PhD | Tech
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • Exploring HIV care and advocacy [PODCAST]

      The Podcast by KevinMD | Podcast
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 3 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

CME Spotlights

From MedPage Today

Latest News

  • What Percent of Kids Had Long COVID?
  • Primary Care Visits With NPs, PAs on the Rise; C. Diff in the Intensive Care Unit
  • Are Obesity Drugs for Adolescents Cost-Effective?
  • Lab Tests That Escape FDA Oversight May Come Under Agency Review
  • Fezolinetant Benefits Women Not Suited for Hormone Therapy

Meeting Coverage

  • Fezolinetant Benefits Women Not Suited for Hormone Therapy
  • Plant-Based Estrogen Improves Lipids in Postmenopausal Women
  • New Schizophrenia Treatments Are Coming: Don't Panic
  • Loneliness Needs to Be Treated Like Any Other Health Condition, Researcher Suggests
  • Stopping Medical Misinformation Requires Early Detection
  • Most Popular

  • Past Week

    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Challenging the diagnosis: dehydration or bias?

      Sydney Lou Bonnick, MD | Physician
    • COVID-19 unleashed an ongoing crisis of delirium in hospitals

      Christina Reppas-Rindlisbacher, MD, Nathan Stall, MD, and Paula Rochon, MD | Conditions
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions
    • Unraveling the complex enigma of obesity [PODCAST]

      The Podcast by KevinMD | Podcast
    • Physician autonomy and patient interactions in corporate health care

      Michele Luckenbaugh | Conditions
  • Past 6 Months

    • Medical gaslighting: a growing challenge in today’s medical landscape

      Tami Burdick | Conditions
    • I want to be a doctor who can provide care for women: What states must I rule out for my medical education?

      Nandini Erodula | Education
    • Balancing opioid medication in chronic pain

      L. Joseph Parker, MD | Conditions
    • The erosion of patient care

      Laura de la Torre, MD | Physician
    • Reigniting after burnout: 3 physician stories

      Kim Downey, PT | Physician
    • Mourning the silent epidemic: the physician suicide crisis and suggestions for change

      Amna Shabbir, MD | Physician
  • Recent Posts

    • Unraveling the complex enigma of obesity [PODCAST]

      The Podcast by KevinMD | Podcast
    • Second chances and simple beauty in thrift stores

      Debbie Moore-Black, RN | Conditions
    • How to facilitate caregiver learning and support to improve clinical care outcomes

      Kerri Milyko, PhD | Tech
    • Air quality alert: Reducing our carbon footprint in health care

      Shreya Aggarwal, MD | Conditions
    • Exploring HIV care and advocacy [PODCAST]

      The Podcast by KevinMD | Podcast
    • A teenager’s perspective: the pressing need for mental health days in schools

      Ruhi Saldanha | Conditions

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Does Linzess have a role in IBS with constipation?
3 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...